| scholarly article | Q13442814 |
| P2093 | author name string | Dunbar EM | |
| Ellis ME | |||
| Mandal BK | |||
| Leen CL | |||
| P433 | issue | 1 | |
| P921 | main subject | HIV/AIDS | Q12199 |
| placebo | Q269829 | ||
| candidiasis | Q273510 | ||
| fluconazole | Q411478 | ||
| AIDS-related complex | Q4651855 | ||
| P304 | page(s) | 55-60 | |
| P577 | publication date | 1990-07-01 | |
| P1433 | published in | Journal of Infection | Q6295344 |
| P1476 | title | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study | |
| P478 | volume | 21 |
| Q43818097 | A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection |
| Q36746886 | Antifungal Agents Used for Deep-Seated Mycotic Infections |
| Q36882122 | Antifungal chemotherapy — Are we winning? |
| Q35374928 | Antifungal prophylaxis during neutropenia and immunodeficiency |
| Q40874801 | Antifungal prophylaxis in immunocompromised hosts |
| Q38970335 | Azole resistance in Candida |
| Q24550731 | Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans |
| Q40466322 | Clinical Parameters Associated with Recalcitrant Oral Candidosis in HIV Infection: A Preliminary Study |
| Q41048512 | Clinical management of oral and perioral candidosis |
| Q42600087 | Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole |
| Q42433035 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes |
| Q37091074 | Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. |
| Q43723795 | Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis |
| Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
| Q37245969 | Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections |
| Q78772772 | Infectious Esophagitis |
| Q24236693 | Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children |
| Q24244997 | Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children |
| Q35226065 | Management of oral health in persons with HIV infection |
| Q36767149 | Management of oral lesions in HIV-positive patients. |
| Q35038446 | Mucosal candidiasis |
| Q40827662 | Options for the management of mucosal candidiasis in patients with AIDS and HIV infection |
| Q44513245 | Oral Candida and Entembacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy |
| Q53947165 | Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis. |
| Q41527229 | The therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome |
| Q42600069 | Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected]. |
| Q36767158 | Use of prophylactic antifungals in the immunocompromised host. |
| Q34517297 | Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis |
| Q73274282 | [Preventive antimycotic therapy of neutropenic and immunosuppressed patients] |
Search more.